title: How to tackle antimalarial resistance?
authors.affiliation: Medicines for Malaria Venture, Geneva, Switzerland.
authors.forename: Didier
authors.identifier: 0000-0002-5594-3204
authors.initials: D
authors.lastname: Leroy
mesh_terms: D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D037621:Artemisinins / Q000494:pharmacology / Q000627:therapeutic use; D000068456:Clinical Studies as Topic; D018432:Drug Resistance, Multiple / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D009154:Mutation; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D010879:Piperazines
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D011804:Quinolines; C031327:artemisinin; C034759:piperaquine; D010879:Piperazines